Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial. The Diabetes Control and Complications (DCCT) Research Group.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Kidney International

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/ki.1995.236PMID 7643540
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Baseline analysis of renal function in the Diabetes Control and Complications Trial. The Diabetes Control and Complications Trial Research Group [corrected].

  1993cited by this paper
• Glomerular filtration rate measurements in clinical trials. Modification of Diet in Renal Disease Study Group and the Diabetes Control and Complications Trial Research Group.

  1993cited by this paper
• The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus.

  1993cited by this paper
• The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

  1993cited by this paper
• Glomerular filtration rate measurements in clinical trials

  1993cited by this paper
• Some large-sample distribution-free estimators and tests for multivariate partially incomplete data from two populations.

  1992cited by this paper
• Long-term glycemic control and kidney function in insulin-dependent diabetes mellitus.

  1992cited by this paper
• The relationship between long-term glycaemic control and diabetic nephropathy.

  1992cited by this paper
• Effect of improved metabolic control on loss of kidney function in Type 1 (insulin-dependent) diabetic patients: an update of the Steno studies

  1991cited by this paper
• Factors Associated With Avoidance of Severe Complications After 25 Yr of IDDM: Pittsburgh Epidemiology of Diabetes Complications Study I

  1990cited by this paper
• The natural history and epidemiology of diabetic nephropathy. Implications for prevention and control.

  1990cited by this paper
• Measurement of renal function in chronic renal disease.

  1990cited by this paper
• Diabetic nephropathy: hemodynamic basis and implications for disease management.

  1989cited by this paper
• Disparities in incidence of diabetic end-stage renal disease according to race and type of diabetes.

  1989cited by this paper
• Glucose control and the renal and retinal complications of insulin-dependent diabetes.

  1989cited by this paper
• Reduction of urinary albumin excretion after 4 years of continuous subcutaneous insulin infusion in insulin-dependent diabetes mellitus. The Oslo Study.

  1988cited by this paper
• Impact of metabolic control in progression of clinical diabetic nephropathy

  1987cited by this paper
• The Natural History of Insulin‐Dependent Diabetes in Denmark: 2. Long‐term survival—who and why

  1987cited by this paper
• Declining Incidence of Persistent Proteinuria in Type I (Insulin-Dependent) Diabetic Patients in Denmark

  1987cited by this paper
• Color photography vs fluorescein angiography in the detection of diabetic retinopathy in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group.

  1987cited by this paper
• Color photography vs fluorescein angiography in the detection of diabetic retinopathy in the diabetes control and complications trial

  1987cited by this paper
• Effect of two years of strict metabolic control on progression of incipient nephropathy in insulin-dependent diabetes.

  1986cited by this paper
• The Diabetes Control and Complications Trial (DCCT). Design and methodologic considerations for the feasibility phase. The DCCT Research Group.

  1986cited by this paper
• Unbalanced repeated-measures models with structured covariance matrices.

  1986cited by this paper
• Early Diabetic Nephropathy: Assessment and Potential Therapeutic Interventions

  1986cited by this paper
• The changing natural history of nephropathy in type I diabetes.

  1985cited by this paper
• Two-Year Experience with Continuous Subcutaneous Insulin Infusion in Relation to Retinopathy and Neuropathy

  1985cited by this paper
• Effect of Insulin Pump Treatment for One Year on Renal Function and Retinal Morphology in Patients with IDDM

  1985cited by this paper
• Two-Sample Asymptotically Distribution-Free Tests for Incomplete Multivariate Observations

  1984cited by this paper
• Blood glucose control and the evolution of diabetic retinopathy and albuminuria. A preliminary multicenter trial.

  1984cited by this paper
• The Randomized clinical trial and therapeutic decisions

  1984cited by this paper
• Glycaemia, arterial pressure and micro-albuminuria in Type 1 (insulin-dependent) diabetes mellitus

  1984cited by this paper
• Incipient nephropathy in Type 1 (insulin-dependent) diabetes

  1984cited by this paper
• Predicting diabetic nephropathy in insulin-dependent patients.

  1984cited by this paper
• Diabetic nephropathy in type 1 (insulin-dependent) diabetes: An epidemiological study

  1983cited by this paper
• Proteinuria in diabetes mellitus: role of spontaneous and experimental variation of glycemia.

  1982cited by this paper
• Random-effects models for longitudinal data.

  1982cited by this paper
• Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus.

  1982cited by this paper
• Early detection of patients at risk of developing diabetic nephropathy. A longitudinal study of urinary albumin excretion.

  1982cited by this paper
• Statistical Methods for Survival Data Analysis

  1981cited by this paper
• Prognosis of diabetics with diabetes onset before the age of thirty-one. II. Factors influencing the prognosis.

  1978cited by this paper
• On the Relation between Change and Initial Value

  1977cited by this paper
• Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

  1972cited by this paper
• Twenty-five to forty-five years of diabetes with and without vascular complications

  1970cited by this paper

• The effect of Tai Chi on glycemic control in type 2 diabetes mellitus: a meta-analysis of randomized controlled trials

  2025cites this paper
• Antidiabetic Effect Of Amaranthus Spinosus

  2025cites this paper
• The Association Between Glomerular Filtration Rate, Cardiometabolic Risk, and HbA1c Levels among Outpatients with Type 2 Diabetes Mellitus in Mopti

  2025cites this paper
• Renal Status in Newly Diagnosed Patients with Diabetes Mellitus: A Descriptive Study in Primary Care and Opportunities for Improving Management

  2025cites this paper
• Hypertension and BMI as Mediators of Type 2 Diabetes-Induced CKD: Insights from an Integrative Multi-Database Study

  2025cites this paper
• Addressing unmet needs for chronic kidney disease treatment in type 1 diabetes: A review

  2025cites this paper
• Artificial intelligence based predictive tools for identifying type 2 diabetes patients at high risk of treatment Non-adherence: A systematic review

  2025cites this paper
• Lessons learned from the FinnDiane Study: Epidemiology and metabolic risk factors for diabetic kidney disease in type 1 diabetes

  2024cites this paper
• Identification of metabolic reprogramming-related genes as potential diagnostic biomarkers for diabetic nephropathy based on bioinformatics

  2024cites this paper
• Classification of longitudinal estimated glomerular filtration rate trajectories in Canadian adults with type 1 diabetes.

  2024cites this paper
• Reference Interval for Glycated Albumin, 1,5-AG/GA, and GA/HbA1c Ratios and Cut-Off Values for Type 1, Type 2, and Gestational Diabetes: A Cross-Sectional Study

  2024cites this paper
• High glucose-induced downregulation of PTEN-Long is sufficient for proximal tubular cell injury in diabetic kidney disease.

  2024cites this paper
• Hyperglycemia - A culprit of podocyte pathology in the context of glycogen metabolism.

  2024cites this paper
• Twenty-Four week Taichi training improves pulmonary diffusion capacity and glycemic control in patients with Type 2 diabetes mellitus

  2024cites this paper
• U-shaped relationship between fasting blood glucose and urinary albumin-to-creatinine ratio in the general United States population

  2024cites this paper
• Renal functional outcomes after nephrectomy in patients with localized renal cell carcinoma and diabetes mellitus: a systematic review and meta-analysis

  2024cites this paper
• Screening, identifying, and treating chronic kidney disease: why, who, when, how, and what?

  2024cites this paper
• A Hybrid Care Model to Manage Diabetes Mellitus in the United Arab Emirates

  2024cites this paper
• Poor glycemic control is associated with more rapid kidney function decline after the onset of diabetic kidney disease.

  2024cites this paper
• Elevated apolipoprotein C3 augments diabetic kidney disease and associated atherosclerosis in type 2 diabetes

  2024cites this paper
• Low Blood Glucose Index Associated with Cardiovascular Events in Diabetic Hemodialysis Patients

  2023cites this paper
• Mortality assessment for pancreas transplants in the United States over the decade 2008-2018

  2023cites this paper
• Glycemic Control and Adverse Clinical Outcomes in Patients with Chronic Kidney Disease and Type 2 Diabetes Mellitus: Results from KNOW-CKD

  2023influential citation
• Differential correlation between time in range and eGFR or albuminuria in type 2 diabetes

  2023cites this paper
• An Insight into the Development of Potential Antidiabetic Agents along with their Therapeutic Targets.

  2023cites this paper
• Managing comorbidities in chronic kidney disease reduces utilization and costs

  2023cites this paper
• Role of Pharmacist in Prevention and Management of Diabetics

  2023cites this paper
• Plasma Biomarkers and Incident CKD Among Individuals Without Diabetes

  2023cites this paper
• Incretin Therapies for Patients with Type 2 Diabetes and Chronic Kidney Disease

  2023cites this paper
• Hyaluronan Inhibition as a Therapeutic Target for Diabetic Kidney Disease: What Is Next?

  2023cites this paper
• The vascular complications of diabetes: a review of their management, pathogenesis, and prevention

  2023cites this paper
• Kidney Considerations in Pediatric Obesity

  2023cites this paper
• Genetic susceptibility to diabetic kidney disease is linked to promoter variants of XOR

  2023cites this paper
• Risk of rapid progression to dialysis in patients with type 2 diabetes mellitus with and without diabetes-related complications at diagnosis

  2023cites this paper
• Heterogeneity in the association between prediabetes categories and reduction on glomerular filtration rate in a 5-year follow-up

  2022cites this paper
• Continuous Glucose Monitoring Metrics in the Assessment of Glycemia in Moderate-to-Advanced CKD in Diabetes

  2022cites this paper
• The 2021–2022 position of Brazilian Diabetes Society on diabetic kidney disease (DKD) management: an evidence-based guideline to clinical practice. Screening and treatment of hyperglycemia, arterial hypertension, and dyslipidemia in the patient with DKD

  2022cites this paper
• Plasma advanced glycation end products and the subsequent risk of microvascular complications in type 1 diabetes in the DCCT/EDIC

  2022cites this paper
• Joint 30-year HbA1c and lipid trajectories and mortality in type 1 diabetes.

  2022cites this paper
• Diabetic Kidney Disease: From Pathogenesis to Novel Treatment Possibilities.

  2022cites this paper
• Evaluation of continuous glucose monitoring‐derived person‐specific HbA1c in the presence and absence of complications in type 1 diabetes

  2022cites this paper
• Emerging drugs for the treatment of diabetic nephropathy

  2022cites this paper
• Evaluation of Serum Levels of Tissue Inhibitor Metalloproteinase-1and Matrix Metalloproteinase-1 in Egyptian Patients with Diabetic Nephropathy

  2022cites this paper
• A simplified prediction model for end-stage kidney disease in patients with diabetes

  2022cites this paper
• Antihypertensive Therapies

  2022cites this paper
• Use of Glucose-Lowering Agents in Diabetes and CKD

  2022cites this paper
• Urine-Based Detection of Biomarkers Indicative of Chronic Kidney Disease in a Patient Cohort from Ghana

  2022cites this paper
• Clin‐Star corner: What is new at the interface of geriatrics and nephrology?

  2022cites this paper
• KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease.

  2022cites this paper
• Implementation of corneal confocal microscopy for screening and early detection of diabetic neuropathy in primary care alongside retinopathy screening: Results from a feasibility study

  2022cites this paper
• Prevalence and Predictors of Albuminuria in Type 2 Diabetes Mellitus Patients: A Cross-Sectional Study from the United Arab Emirates.

  2022cites this paper
• Comparing Multiple Linear Regression and Machine Learning in Predicting Diabetic Urine Albumin–Creatinine Ratio in a 4-Year Follow-Up Study

  2022cites this paper
• Making an impact on kidney disease in people with type 2 diabetes: the importance of screening for albuminuria

  2022cites this paper
• An Assessment of How Clinicians and Staff Members Use a Diabetes Artificial Intelligence Prediction Tool: Mixed Methods Study

  2022cites this paper
• Diabetic nephropathy: Clinical presentation, course, and novel treatment possibilities

  2022cites this paper
• Clinical and economic benefits of continuous blood glucose monitoring devices

  2022cites this paper
• Laser-Assisted Surface Modification of Ni Microstructures with Au and Pt toward Cell Biocompatibility and High Enzyme-Free Glucose Sensing

  2021cites this paper
• Decision models in type 2 diabetes mellitus: A systematic review

  2021cites this paper
• Effects of metabolic memory on inflammation and fibrosis associated with diabetic kidney disease: an epigenetic perspective

  2021cites this paper
• Heterogeneity in the Association Between Prediabetes Categories and Development of Impaired Renal Function in A 5-Year Follow-Up

  2021cites this paper
• Hub Genes Associated with the Diagnosis of Diabetic Retinopathy

  2021cites this paper
• Factors Associated with Glycaemic Control among Diabetic Subjects in Essaouira Province, Morocco: A Cross-Sectional Study

  2021cites this paper
• Management of Diabetes 100 Years After the Discovery of Insulin: Nuances for the Kidney

  2021cites this paper
• Prevalence and risk factors of urinary incontinence among Iranian women

  2021cites this paper
• Management of Diabetes Mellitus in Patients With CKD: Core Curriculum 2022.

  2021cites this paper
• A Validated Prediction Model for End-Stage Kidney Disease in Type 1 Diabetes

  2021cites this paper
• Nutrition and Obesity in the Pathogenesis of Youth-Onset Type 1 Diabetes and Its Complications

  2021cites this paper
• Identifying Clinical and Genomic Features Associated With Chronic Kidney Disease

  2021cites this paper
• Macro and microangiopathy related to retinopathy and choroidopathy in type 2 diabetes

  2021cites this paper
• Decision Points in the Management of Patients with Diabetic Kidney Disease.

  2021cites this paper
• Renal hemodynamic effects differ between antidiabetic combination strategies: randomized controlled clinical trial comparing empagliflozin/linagliptin with metformin/insulin glargine

  2021cites this paper
• Renal function in patients following a low carbohydrate diet for type 2 diabetes: a review of the literature and analysis of routine clinical data from a primary care service over 7 years

  2021cites this paper
• Reduction in cardiovascular mortality following severe hypoglycemia in individuals with type 2 diabetes: the role of a pragmatic and structured intervention

  2021cites this paper
• The variability of glycated hemoglobin is associated with renal function decline in patients with type 2 diabetes

  2020cites this paper
• Diabetic Nephropathy – Research

  2020cites this paper
• Microvascular Complications of Type 1 Diabetes Mellitus Screening in Children, Adolescents and Young Adults: Report from a Small Center in a Limited Resource Setting, Brazzaville - Congo

  2020cites this paper
• Heterogeneity in the Association Between Prediabetes Categories and Development of Impaired Renal Function in A 5-Year Follow-Up 

  2020cites this paper
• Facilitators and barriers to self-monitoring of blood glucose (SMBG) in diabetic patients visiting family medicine clinics at Akuh. 

  2020cites this paper
• Molecular complexities underlying the vascular complications of diabetes mellitus - A comprehensive review.

  2020cites this paper
• Management of Diabetes Mellitus in Acute and Chronic Cardiorenal Syndromes

  2020cites this paper
• The Severity of Diabetic Retinopathy Is an Independent Factor for the Progression of Diabetic Nephropathy

  2020cites this paper
• A Kinetic Model for Glucose Levels and Hemoglobin A1c Provides a Novel Tool for Individualized Diabetes Management

  2020cites this paper
• Fasting plasma glucose variability is an independent risk factor for diabetic retinopathy and diabetic macular oedema in type 2 diabetes: An 8‐year prospective cohort study

  2020cites this paper
• Incidence of Chronic Kidney Disease and Its Association with Fasting Blood Sugar Change Among Diabetic Patients in Resource Limited Setting in Case of Ethiopia: Bayesian Joint Modeling

  2020cites this paper
• Facilitators and Barriers to Self-Monitoring of Blood Glucose (SMBG) in Diabetic Patients

  2020cites this paper
• KDIGO 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease.

  2020cites this paper
• Diabetic kidney disease: seven questions

  2020cites this paper
• Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.

  2020cites this paper
• Laser-Induced Synthesis of Composite Materials Based on Iridium, Gold and Platinum for Non-Enzymatic Glucose Sensing

  2020cites this paper
• Progression of Diabetic Retinopathy and Declining Renal Function in Patients with Type 2 Diabetes

  2020cites this paper
• Mikroalbuminurie und kardiovaskuläre Erkrankungen in Österreich: Ergebnisse der TIP (Tritace In Proteinuria)-Anwendungsbeobachtung

  2020cites this paper
• Founding papers of current nephrology: from acute kidney injury to diabetic kidney disease.

  2020cites this paper
• Omics research in diabetic kidney disease: new biomarker dimensions and new understandings?

  2020cites this paper
• Impaired Glomerular Filtration Rate in Type 2 Diabetes Mellitus Subjects: A Nationwide Cross-Sectional Study in Thailand

  2020cites this paper
• Serum cystatin C as an indicator for early detection of diabetic nephropathy in type 2 diabetes mellitus.

  2019cites this paper
• Diabetic Kidney Disease

  2019cites this paper
• Measurement and Estimation of Kidney Function

  2019cites this paper
• Diabetic Kidney Disease

  2019cites this paper
• Donor-related diabetic nephropathy: a comprehensive clinicopathological study.

  2019cites this paper
• The short‐term effects of angiotensin II receptor blockers on albuminuria and renal function in Korean patients

  2019cites this paper